- Home
- VIGL vs CEE Comparison
VIGL vs CEE Comparison
Compare VIGL & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- CEE
- Stock Information
- Founded
- VIGL 2020
- CEE 1990
- Country
- VIGL United States
- CEE Germany
- Employees
- VIGL N/A
- CEE N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- VIGL Health Care
- CEE Finance
- Exchange
- VIGL Nasdaq
- CEE Nasdaq
- Market Cap
- VIGL 74.7M
- CEE 83.8M
- IPO Year
- VIGL 2022
- CEE N/A
- Fundamental
- Price
- VIGL $2.41
- CEE $14.75
- Analyst Decision
- VIGL Strong Buy
- CEE
- Analyst Count
- VIGL 5
- CEE 0
- Target Price
- VIGL $16.33
- CEE N/A
- AVG Volume (30 Days)
- VIGL 164.4K
- CEE 22.0K
- Earning Date
- VIGL 05-07-2025
- CEE 01-01-0001
- Dividend Yield
- VIGL N/A
- CEE 3.86%
- EPS Growth
- VIGL N/A
- CEE N/A
- EPS
- VIGL N/A
- CEE N/A
- Revenue
- VIGL N/A
- CEE N/A
- Revenue This Year
- VIGL N/A
- CEE N/A
- Revenue Next Year
- VIGL N/A
- CEE N/A
- P/E Ratio
- VIGL N/A
- CEE N/A
- Revenue Growth
- VIGL N/A
- CEE N/A
- 52 Week Low
- VIGL $1.31
- CEE $7.80
- 52 Week High
- VIGL $6.06
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- VIGL 60.07
- CEE 56.58
- Support Level
- VIGL $1.75
- CEE $14.54
- Resistance Level
- VIGL $3.00
- CEE $14.93
- Average True Range (ATR)
- VIGL 0.26
- CEE 0.40
- MACD
- VIGL 0.08
- CEE 0.06
- Stochastic Oscillator
- VIGL 55.30
- CEE 76.92
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.